A case of hypersensitivity pneumonitis in a worker exposed to terephthalic acid in the production of polyethylene terephthalate.


Journal

International journal of occupational medicine and environmental health
ISSN: 1896-494X
Titre abrégé: Int J Occup Med Environ Health
Pays: Poland
ID NLM: 9437093

Informations de publication

Date de publication:
17 Jan 2020
Historique:
pubmed: 7 11 2019
medline: 17 9 2020
entrez: 7 11 2019
Statut: ppublish

Résumé

Occupational hypersensitivity pneumonitis (OHP) is an interstitial lung disease caused by sensitization to an inhaled antigen. Polyethylene terephthalate (PET) is mainly used for disposable beverage bottles. A clinical case of hypersensitivity pneumonitis (HP) in a 66-year-old patient in the follow-up as a worker formerly exposed to asbestos is presented. At the first visit in 2012 a diagnosis of asbestosis and pleural plaques was formulated. In 2017 the high resolution computed tomography was performed demonstrating a slight progression of the pulmonary fibrosis, while physical examinations revealed inspiratory crackles on auscultation, and lung function tests showed a decreased diffusing capacity for carbon monoxide. The radiological and histological pictures were compatible with HP. From 1992 to 2013 the patient worked in a chemical company that produced PET for disposable beverage bottles. A diagnosis of OHP was made, and the most likely causative agents were terephthalic acid and dimethyl terephthalate. To the best of the authors' knowledge, this is the first report of an OHP case in PET production. Int J Occup Med Environ Health. 2020;33(1):119-23.

Identifiants

pubmed: 31691678
pii: 112260
doi: 10.13075/ijomeh.1896.01465
pii:
doi:

Substances chimiques

Phthalic Acids 0
Polyethylene Terephthalates 0
terephthalic acid 6S7NKZ40BQ
dimethyl 4-phthalate IKZ2470UNV

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

119-123

Informations de copyright

This work is available in Open Access model and licensed under a CC BY-NC 3.0 PL license.

Auteurs

Pietro Sartorelli (P)

University of Siena, Siena, Italy (Department of Medical Biotechnology, Unit of Occupational Medicine, University Hospital of Siena).

Gabriele d'Hauw (G)

University of Siena, Siena, Italy (Department of Medical Biotechnology, Unit of Occupational Medicine, University Hospital of Siena).

Donatella Spina (D)

University Hospital of Siena, Siena, Italy (Unit of Pathology).

Luca Volterrani (L)

University of Siena, Siena, Italy (Department of Medicine, Surgery and Neuroscience, Unit of Diagnostic Imaging, University Hospital of Siena).

Maria Antonietta Mazzei (MA)

University of Siena, Siena, Italy (Department of Medicine, Surgery and Neuroscience, Unit of Diagnostic Imaging, University Hospital of Siena).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH